American Vanguard's Subsidiary AMVAC Signs MoU with Trimble

Tablet displaying intraday stock performance

American Vanguard CorporationAVD announced that its fully-owned subsidiary AMVAC Chemical Corporation has signed a non-binding Memorandum of Understanding (MoU) with Trimble Inc.

Both companies will collaborate for a definitive agreement that will grant Trimble global distribution rights for the patent-pending Smart Integrated Multi-Product Prescription Application System (SIMPAS) developed by AMVAC. The deal is expected to be completed by the end of 2017.

SIMPAS is a multi-product variable rate system that can be controlled by a Trimble display to automate and vary up to three inputs across a field. The application equipment helps to prescriptively apply multiple, in-furrow dry and/or liquid products (insecticides, nematicides, fungicides, nutritionals and/or biologicals) while planting as well as enable farmers to apply the right product, at the right time, at the right place, at the right rate.

Per the terms of the deal, Trimble's Vantage distribution network will provide easy installation and servicing of the SIMPAS technology throughout North America and across other global markets. Additionally, the use of Trimble application control and software integration along with SIMPAS application equipment will enable farmers to control and manage multiple inputs in the field.

American Vanguard's shares have gained 15.5% over the last three months, outperforming the 1.8% decline of the industry it belongs to.

The company's profit for second-quarter 2017 was $4.3 million or 15 cents per share, up around 33% from $3.2 million or 11 cents a year ago. Earnings per share beat the Zacks Consensus Estimate by a penny. Revenues rose 7% year over year to $77.9 million in the reported quarter, coming ahead of the Zacks Consensus Estimate of $77 million.

American Vanguard, in its second-quarter call, said that outlook for the balance of 2017 is positive. The company noted that significant increase in cotton acreage in the U.S. will likely lead to increased sales of its Bidrin foliar insecticides and Folex harvest defoliants in the second half of 2017.

American Vanguard also sees modest international growth and a rebound in its soil fumigant business. Moreover, the company expects continued demand for its Dibrom mosquito adulticide. The company remains focused on managing working capital and operational costs and investing in technology innovation for future growth.

American Vanguard Corporation Price and Consensus

American Vanguard Corporation Price and Consensus | American Vanguard Corporation Quote

Zacks Rank & Key Picks

American Vanguard currently carries a Zacks Rank #3 (Hold).

Some better-ranked companies in the chemical space include BASF SE BASFY , The Chemours Company CC and Kronos Worldwide KRO . All three stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here.

BASF has an expected long-term earnings growth of 8.6%.

Chemours has an expected long-term earnings growth of 15.5%.

Kronos Worldwide has an expected long-term earnings growth of 5%.

Zacks' 10-Minute Stock-Picking Secret

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

But here's something even more remarkable: You can master this proven system without going to a single class or seminar. And then you can apply it to your portfolio in as little as 10 minutes a month.

Learn the secret >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

BASF SE (BASFY): Free Stock Analysis Report

Kronos Worldwide Inc (KRO): Free Stock Analysis Report

Chemours Company (The) (CC): Free Stock Analysis Report

American Vanguard Corporation (AVD): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos


Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

Learn More